Dolby Laboratories (NYSE:DLB) Updates FY 2025 Earnings Guidance

Dolby Laboratories (NYSE:DLBGet Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 3.990-4.140 for the period, compared to the consensus earnings per share estimate of 3.700. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.3 billion. Dolby Laboratories also updated its FY25 guidance to $2.43-2.58 EPS.

Dolby Laboratories Stock Performance

Shares of DLB stock traded down $0.42 during trading hours on Tuesday, hitting $70.93. The company had a trading volume of 416,799 shares, compared to its average volume of 396,175. Dolby Laboratories has a 12 month low of $66.35 and a 12 month high of $90.06. The firm’s fifty day moving average is $73.66 and its 200 day moving average is $76.09. The firm has a market capitalization of $6.76 billion, a price-to-earnings ratio of 32.38 and a beta of 0.98.

Dolby Laboratories declared that its board has initiated a stock repurchase program on Wednesday, August 7th that authorizes the company to buyback $350.00 million in shares. This buyback authorization authorizes the electronics maker to repurchase up to 5% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s board of directors believes its stock is undervalued.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on DLB shares. Barrington Research restated an “outperform” rating and issued a $100.00 target price on shares of Dolby Laboratories in a research note on Friday, September 20th. StockNews.com raised shares of Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a research note on Monday.

Get Our Latest Report on Dolby Laboratories

Insider Buying and Selling

In other news, CEO Kevin J. Yeaman sold 28,512 shares of the company’s stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of $74.12, for a total transaction of $2,113,309.44. Following the transaction, the chief executive officer now directly owns 83,721 shares in the company, valued at approximately $6,205,400.52. This represents a 25.40 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 39.54% of the stock is owned by corporate insiders.

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Read More

Earnings History and Estimates for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.